Cancel
Asher Bio
Asher Bio Employees
9 people indexed:
-
jl4kx8@v1t1ftx5.33f Sign up to see email
-
uu8731@zvk4fftt.t3p Sign up to see email
-
y9.qgpk7zjq@t35205yg.6xk Sign up to see email
-
6136z394y@775v7n85.z6g Sign up to see email
-
3kzwxn@8g5xffyf.5vf Sign up to see email
-
5508p80p@k5gqx2qg.410 Sign up to see email
-
y982yy@9xg03tu1.1wu Sign up to see email
-
5x73yz@7kv52w6j.yw5 Sign up to see email
-
w6x51l@f82lfwwz.5gp Sign up to see email
Asher Bio Company Information
Asher Bio, formerly known as Asher Biotherapeutics, is a biotechnology company located in South San Francisco, California. It specializes in the development of cis-targeted immunotherapies for a range of serious diseases including cancer, autoimmune disorders, and infectious diseases. The company’s leading product, AB248, is a cis-targeted IL-2 immunotherapy designed specifically for solid tumors and has demonstrated superior anti-tumor activity in preclinical models compared to traditional IL-2 therapies. Asher Bio’s pipeline also includes other promising candidates such as AB821 and AB359. The company’s innovative cis-targeting platform enables the selective activation of specific immune cell types, aiming to improve efficacy and minimize toxicity compared to conventional immunotherapies. Asher Bio is supported by a strong investment group including Third Rock Ventures, Wellington Management, and Y Combinator, among others. The company’s leadership and advisory boards are comprised of experienced professionals and renowned scientists in the field of immunotherapy. Asher Bio also offers competitive employee benefits and is situated in a major biotech hub, enhancing its operational capabilities and access to industry resources.
Report inaccurate information
Report inaccurate information